Physician profile
Shane O Smith
NPI 1609199876
$960.47
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $541 · 2022: $388 · 2024: $31.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $129.98 | 2022 | |
| Abbott Laboratories | $103.94 | 2021-2022 | |
| Amgen INC. | $72.48 | 2021 | |
| Collegium Pharmaceutical, INC. | $71.80 | 2021-2022 | |
| Abbvie INC. | $49.13 | 2021 | |
| Biotissue Holdings INC. | $48.73 | 2021 | |
| Redhill Biopharma INC. | $45.51 | 2021 | |
| Tersera Therapeutics LLC | $45.30 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.46 | 2022 | |
| Almatica Pharma LLC | $44.10 | 2021 | |
| Grt US Holding, INC. | $36.93 | 2022 | |
| Boston Scientific Corporation | $32.73 | 2022 | |
| Pfizer INC. | $31.44 | 2024 | |
| Arbor Pharmaceuticals, INC. | $31.29 | 2021 | |
| Ibsa Pharma INC. | $29.00 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $28.27 | 2022 | |
| Merz Pharmaceuticals, LLC | $25.68 | 2021 | |
| Fidia Pharma USA INC. | $22.61 | 2022 | |
| Lundbeck LLC | $19.90 | 2022 | |
| Uswm, LLC | $17.07 | 2021 | |
| Horizon Therapeutics Plc | $16.49 | 2021 | |
| Biodelivery Sciences International, INC. | $13.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.